Protective effect of melatonin against oxidative hepatic injury after experimental thermal trauma.
Burns cause thermal injury to local tissue, trigger systemic inflammatory processes and activate lipid peroxidation, leading to multiple distant organ injury. Melatonin is a lipid- and water-soluble antioxidant and membrane stabilizer with antiinflammatory, hepatoprotective and gastroptotective properties, among others. We studied the influence of melatonin on hepatic damage induced by thermal skin injury and its possible relation to hepatic lipid peroxidative status and systemic inflammatory response. Under ether anesthesia the shaved dorsum of rats was exposed to a 90 degrees C bath for 10 s. Melatonin was administered intraperitoneally immediately after burns. Malondialdehyde (MDA), aspartate transaminase (AST) and alanine transaminase (ALT) were determined in liver and blood plasma and used as markers of oxidative status. Plasma C-reactive protein (CRP) was used as a marker of systemic inflammatory response. Thermal skin injury caused significant elevation of hepatic MDA by 48%, plasma CRP levels by 30% and plasma AST and ALT activities by 2- and 3.5-fold, respectively, in comparison with normal control rats. Treatment with melatonin (10 mg/kg) significantly inhibited the elevation in hepatic MDA and plasma CRP levels, reaching control values at 24 h. Melatonin treatment restricts the elevation of plasma AST and ALT activities (P < 0.001), which remain significantly increased as compared with controls. In conclusion, the protective effect of melatonin is likely to be due to attenuated lipid peroxidation and interference with reduced oxidative stress and inflammatory response, as evidenced by decreased hepatic MDA and plasma CRP levels.
Bekyarova
G
G
Department of Pathophysiology, Medical University of Varna, Varna, Bulgaria. gabekyarova2001@yahoo.com
Tancheva
S
S
Hristova
M
M
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002056:Burns / Q000188:drug therapy* / Q000503:physiopathology; D002097:C-Reactive Protein / Q000187:drug effects / Q000378:metabolism; D004195:Disease Models, Animal; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology; D007274:Injections, Intraperitoneal; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D008111:Liver Function Tests; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008550:Melatonin / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D012867:Skin / Q000187:drug effects / Q000503:physiopathology
D000975:Antioxidants; D008315:Malondialdehyde; D002097:C-Reactive Protein; D008550:Melatonin